Daxor Corporation - Closed End Fund (DXR) analyst actions
Rating and price-target actions on DXR in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the DXR overview →
1 measured DXR analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Daxor Broadens Outpatient Footprint with Initiation of ezBVA Lab Diagnostic Services in Kansas | Press release | — | — |
Keep exploring
More DXR: earnings → · SEC filings → · DXR overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| InfuSystems Holdings, Inc. (INFU) | 202 | 0.00% | 50% |
| Regulus Therapeutics Inc. (RGLS) | 201 | +0.26% | 55% |
| The Joint Corp. (JYNT) | 200 | 0.00% | 45% |
| ProPhase Labs, Inc. (PRPH) | 198 | -0.18% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.